A 35-year-old multiparous woman with a history of one episode of pelvic inflammatory disease (PID) 3 years ago (treated successfully with antibiotics) presents for contraceptive counseling. She has had no recurrent infections and her partner is monogamous. She requests a long-acting reversible contraceptive. On examination, her vitals are normal and pelvic examination is unremarkable. Which IUCD is most appropriate, and what is the key contraceptive mechanism?

## Clinical Context This patient has a remote history of PID (3 years ago, successfully treated, no recurrence, monogamous partner). The question tests both device selection in this scenario AND understanding of copper IUCD mechanism. ## Why Copper IUCD is Correct **Key Point:** A history of PID is NOT an absolute contraindication to IUCD insertion if the infection was treated and there is no ongoing risk of STI or recurrent PID [cite:WHO Medical Eligibility Criteria 5e; Park 26e Ch 34]. This patient meets criteria for safe insertion. **High-Yield:** The copper IUCD works primarily through a **sterile inflammatory response** that is toxic to sperm and impairs their motility and viability. This local copper-induced inflammation is NOT the same as PID (which is bacterial infection) and does NOT increase PID risk in low-risk women [cite:FIGO Guidelines on IUCD]. ## Mechanism of Copper IUCD **Mnemonic: TOXIC** — **T**oxic to sperm, **O**vum transport impaired, **X**anthine oxidase (copper enzyme), **I**nflammatory response (sterile), **C**ervical mucus thickening (minor role). 1. **Spermicidal effect:** Copper ions are directly toxic to sperm, reducing motility and viability. 2. **Inflammatory response:** The copper-induced sterile inflammatory response creates a hostile endometrial environment. 3. **Impaired ovum transport:** Altered tubal motility reduces ovum transport. 4. **Cervical mucus:** Minor thickening of mucus (secondary effect). ## Comparison of Devices in This Patient | Feature | Copper IUCD | LNG-IUS | | --- | --- | --- | | **Safety in prior PID** | Safe if remote, treated, low recurrence risk | Also safe; no increased PID risk | | **Primary mechanism** | Sterile inflammatory response (spermicidal) | Endometrial suppression + cervical mucus thickening | | **Efficacy** | 0.8 per 100 woman-years | 0.2 per 100 woman-years | | **Effect on menstruation** | May increase bleeding | Decreases bleeding | | **Cost** | Lower | Higher | | **Duration** | 10 years | 5–7 years | **Clinical Pearl:** The sterile inflammatory response induced by copper is a FEATURE, not a bug. It is the primary mechanism of contraceptive action and does NOT increase infection risk in women without active STI or ongoing high-risk behavior. ## Why This Patient Can Use Copper IUCD - PID was 3 years ago (remote history). - Infection was treated successfully. - No recurrent infections. - Partner is monogamous (low STI risk). - Pelvic examination is normal. **Warning:** IUCD insertion is contraindicated in women with CURRENT PID or high risk of STI (multiple partners, partner with STI, or recent STI). This patient does NOT meet those criteria.